Lack of Clinically Relevant Pharmacokinetic Drug-Drug Interaction between Norgestimate/Ethinyl Estradiol and Pangenotypic HCV NS5A Inhibitor GS-5816 in HCV-Uninfected Female Subjects

被引：0

作者：

Mogalian, Erik ^{[1
]}

Brainard, Diana M. ^{[1
]}

McNally, John ^{[1
]}

Shen, Gong ^{[1
]}

Cuvin, Jennifer ^{[1
]}

Mathias, Anita ^{[1
]}

机构：

[1] Gilead Sci Inc, Foster City, CA 94404 USA

来源：

HEPATOLOGY | 2014年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1998

引用

页码：1173A / 1173A

页数：1

共 12 条

[11] Pharmacokinetics and Drug-Drug Interaction between Samatasvir, an NS5A Inhibitor, and Co-administered Simeprevir, an NS3/4A Protease Inhibitor, and Low Dose Ritonavir-Boosted TMC647055, a Non-Nucleoside NS5B Inhibitor, in Healthy Volunteers and HCV-Infected Subjects [J].

Zhou, Xiao-Jian ;

Pietropaolo, Keith ;

Frank, Dodie ;

Chen, Jie ;

van Heeswijk, Rolf ;

Sullivan-Bolyai, John ;

Van Remoortere, Pieter ;

Verloes, Rene ;

Mayers, Douglas L. .

HEPATOLOGY, 2014, 60 :1167A-1168A

[12] EVALUATION OF PHARMACOKINETIC DRUG-DRUG INTERACTION (DDI) BETWEEN BMS-791325, AN NS5B NON-NUCLEOTIDE POLYMERASE INHIBITOR, DACLATASVIR AND ASUNAPREVIR IN TRIPLE COMBINATION IN HCV GENOTYPE 1-INFECTED PATIENTS [J].

Wang, X. ;

Li, W. ;

Huang, S. -P. ;

He, B. ;

Chung, E. ;

Griffies, A. ;

Cooney, E. ;

Hughes, E. ;

Kandoussi, H. ;

Sims, K. ;

Gardiner, D. ;

Bertz, R. ;

Eley, T. .

JOURNAL OF HEPATOLOGY, 2013, 58 :S184-S184

← 1 2 →